APRIL TATE: Open Payments
NPI 1801446190 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,467 in 37 payments from 8 companies in 2025. Trend: 2023 $7,896 · 2024 $3,033 · 2025 $1,467
Speaker / faculty: $1,000Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $1,142 |
| Lilly USA, LLC | 9 | $124 |
| Novo Nordisk Inc | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Smith+Nephew, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $19 |
Products named: REPATHA, MOUNJARO, OTEZLA, LEQVIO, Ozempic, EVENITY, BREZTRI, COLLAGENASE SANTYL.
Industry payments across AL — which companies pay providers there.
